Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting the chromatin binding domains of BPTF for neuroblastoma epigenetic therapy
Pomerantz, W. C. (PI)
ST. JUDE MEDICAL, INC., NATIONAL INSTITUTES OF HEALTH (NIH)
1/1/25 → 12/31/25
Project: Research project
-
Enhancing Tumor Cell Immunogenicity using Improved Molecules Targeting Chromatin Remodeling
Pomerantz, W. C. (PI)
VIRGINIA COMMONWEALTH UNIVERSITY, NATIONAL INSTITUTES OF HEALTH (NIH)
12/13/23 → 11/30/25
Project: Research project
-
Fluorine Beyond PFAS: Pathways to Sustainable Fluorochemical Design Through Environmental Degradation Studies and Fluorine Mass Balances
Arnold, B. (PI), Behrens, S. F. (CoI) & Pomerantz, W. C. (CoI)
THE NATIONAL SCIENCE FOUNDATION
7/1/23 → 6/30/26
Project: Research project
-
Quantification of total PFAS concentrations and PFAS binding using 19F-nuclear magnetic resonance spectroscopy
Peterson, J. M. (PI), Arnold, B. (CoI) & Pomerantz, W. C. (CoI)
12/19/22 → 12/16/25
Project: Research project
-
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
Pomerantz, W. C. (PI)
NIH NIGMS NATL INST OF GENERAL
4/1/21 → 1/31/26
Project: Research project
-
Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease
Doskey, L. C., Scholtz, C. R., Vail, N. R., Khanal, S., Lee, A. L., Kandanur, S. G. S., Hoell, Z. J., Huehls, A. M., Issa, M. R., Kostallari, E., Cao, S., Reid, J. M., Shah, V. H., Malhi, H. & Pomerantz, W. C. K., Apr 24 2025, In: Journal of medicinal chemistry. 68, 8, p. 8091-8105 15 p.Research output: Contribution to journal › Article › peer-review
-
Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors
Jiang, J., Liang, T., Solberg, J., Chan, A., Kalra, P., Shi, R., Pomerantz, W. C. K., Hawkinson, J. E., Schönbrunn, E. & Georg, G. I., Jun 5 2025, In: European Journal of Medicinal Chemistry. 290, 117504.Research output: Contribution to journal › Article › peer-review
-
Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitors
Rasmussen, D. M., Semonis, M. M., Greene, J. T., Muretta, J. M., Thompson, A. R., Toledo Ramos, S., Thomas, D. D., Pomerantz, W. C. K., Freedman, T. S. & Levinson, N. M., May 14 2024, In: eLife. 13, 13:RP95481.Research output: Contribution to journal › Article › peer-review
Open Access -
Celebrating the 60th Anniversary of the MIKIW Meeting-in-Miniature: Virtual Special Issue
Moore, T. W. & Pomerantz, W. C. K., May 9 2024, In: ACS Medicinal Chemistry Letters. 15, 5, p. 565-566 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Celebrating the 60th Anniversary of the MIKIW Meeting-in-Miniature: Virtual Special Issue
Moore, T. W. & Pomerantz, W. C. K., May 9 2024, In: Journal of medicinal chemistry. 67, 9, p. 6895-6896 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access